Our results show that TP-0903 both decreases Bcl-2 and Mcl-1 levels in NB cells, implicating that TP-0903 not only triggers apoptosis but also reduces apoptosis evasion in NB treatment. This evidence concerns the gene BCL2 and neuroblastoma.